iifl-logo-icon 1

Lincoln Pharmaceuticals Ltd Cash Flow Statement

644.25
(-2.50%)
Oct 22, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Lincoln Pharma. FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2018Mar-2017Mar-2016

Profit before tax

64.04

43.09

35.74

30.05

Depreciation

-5.46

-4.39

-3.85

-3.21

Tax paid

-14.48

-10.34

-8.33

-8.31

Working capital

-8.51

25.15

13.34

-4.84

Other operating items

Operating

35.58

53.5

36.89

13.69

Capital expenditure

17.36

18.79

-7.95

28.86

Free cash flow

52.94

72.29

28.94

42.55

Equity raised

437.46

339.36

270.64

197.3

Investing

21.29

2.73

16

7.34

Financing

-40.67

18.98

14.05

29.94

Dividends paid

3

3

2.39

1.63

Net in cash

474.03

436.37

332.03

278.76

Lincoln Pharma. : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp